Jordi Espadaler-Mazo (Jordi Espadaler)

Years Active: 2016-2022
Publications (10 Years): 5

AB-BIOTICS S.A:

Universitat Autònoma de Barcelona (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AB-BIOTICS S.A:

Spain

Director :: Innovation

Education History

Universitat Autònoma de Barcelona Jan 1o 2001 - Apr 21o 2006

Spain

PHD :: Molecular Biology

Publications

Pedro Gutiérrez-Castrellón, Tania Gandara-Martí, Ana T Abreu Y Abreu, Cesar D Nieto-Rufino, Eduardo López-Orduña, Irma Jiménez-Escobar, Carlos Jiménez-Gutiérrez, Gabriel López-Velazquez, Jordi Espadaler-Mazo
Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial. Gut microbes 14 (1) (2022)
Tatiana Altadill, Jordi Espadaler-Mazo, Min-Tze Liong
Effects of a Lactobacilli Probiotic on Reducing Duration of URTI and Fever, and Use of URTI-Associated Medicine: A Re-Analysis of a Randomized, Placebo-Controlled Study. Microorganisms 9 (3) (2021)
Rafael Guerrero-Bonmatty, Guadalupe Gil-Fernández, Francisco José Rodriguez-Velasco, Jordi Espadaler-Mazo
A Combination of Lactoplantibacillus plantarum Strains CECT7527, CECT7528, and CECT7529 Plus Monacolin K Reduces Blood Cholesterol: Results from a Randomized, Double-Blind, Placebo-Controlled Study. Nutrients 13 (4) (2021)
Erola Astó, Iago Méndez, Sergi Audivert, Andreu Farran-Codina, Jordi Espadaler-Mazo
The Efficacy of Probiotics, Prebiotic Inulin-Type Fructans, and Synbiotics in Human Ulcerative Colitis: A Systematic Review and Meta-Analysis. Nutrients 11 (2) (2019)
Jordi Espadaler-Mazo, Miquel Tuson, Jose Miguel Lopez-Ibor, Franciso Lopez-Ibor, Maria Ines Lopez-Ibor
Pharmacogenetic testing for the guidance of psychiatric treatment: a multicenter retrospective analysis. CNS spectrums 22 (4) (2016)

Jordi Espadaler-Mazo.css-eqlu8i{font-size:small;padding-left:4px;} (Jordi Espadaler)